An Important Message from Ken Keller, President & CEO
The health and safety of American Regent’s employees and customers are our highest priorities.
Over 50 Years of Specialty Injectables
American Regent develops, manufactures and supplies high-quality sterile injectables for healthcare providers and their patients.
Dedicated to Alleviating Drug Shortages
We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients.
American Regent Introduces Estradiol Valerate Injection, USP; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2
Shirley, NY – American Regent announces the introduction and availability of Estradiol Valerate Injection, USP
Melville, NY – September 30, 2020: American Regent, Inc. announces the introduction of Tralement® (trace elements injection 4*, USP), the first and only FDA-approved multi-trace element injection.
American Regent Introduces niCARdipine Hydrochloride Injection, USP; Therapeutically Equivalent to Cardene®
Shirley, NY – May 7, 2020: American Regent announced the introduction of the only FDA approved USP standard Nicardipine Hydrochloride Injection.